BICX OTC
BioCorRx Inc.
1W: +0.0%
1M: -4.3%
3M: -49.8%
YTD: -30.9%
1Y: -5.2%
3Y: -90.2%
5Y: -94.9%
$0.20
+0.00 (+0.00%)
Weekly Expected Move ±22.6%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$8K
-91.4% ▼
5Y CAGR: -49.8%
Gross Profit
$6K
-88.7% ▼
5Y CAGR: -48.1%
Operating Income
-$5M
-35.2% ▼
Net Income
-$5M
-35.6% ▼
EPS (Diluted)
$-0.49
-8.9% ▼
EBITDA
-$4M
-33.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $123K | $48K | $214K | $89K | $8K |
| YoY Growth | -49.0% | -60.6% | +343.0% | -58.3% | -91.4% |
| Cost of Revenue | $96K | $6K | $15K | $36K | $2K |
| Gross Profit | $27K | $42K | $199K | $53K | $6K |
| Gross Margin | 21.8% | 87.8% | 92.9% | 59.6% | 78.3% |
| R&D Expenses | $4M | $2M | $1M | $891K | $1M |
| SG&A Expenses | $3M | $4M | $3M | $3M | $4M |
| Operating Expenses | $3M | $5M | $3M | $4M | $5M |
| Operating Income | -$3M | -$5M | -$3M | -$4M | -$5M |
| Operating Margin | -2468.9% | -9389.9% | -1360.1% | -4248.3% | -66829.8% |
| Interest Expense | $511K | $566K | $1M | $887K | $2M |
| Income Before Tax | -$4M | -$5M | -$4M | -$4M | -$5M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$4M | -$6M | -$4M | -$4M | -$5M |
| Net Margin | -3274.3% | -12021.8% | -2043.3% | -4224.9% | -66616.1% |
| EPS (Diluted) | $-0.75 | $-0.89 | $-0.61 | $-0.45 | $-0.49 |
| EBITDA | -$3M | -$4M | -$3M | -$3M | -$4M |
| Shares Outstanding | 5M | 6M | 7M | 8M | 10M |